3D printed PLGA implants: APF DDM vs. FDM.

Bassand, Celine; Benabed, L.; Charlon, S.; Verin, Jérémy; Freitag, J.; Siepmann, Florence; Soulestin, J.; Siepmann, Juergen

Type de document :

Article dans une revue scientifique: Article original

DOI :

10.1016/j.jconrel.2022.11.052

PMID :

36464064

URL permanente :

http://hdl.handle.net/20.500.12210/79185

Titre :

3D printed PLGA implants: APF DDM vs. FDM.

Auteur(s) :

Bassand, Celine [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Benabed, L. [Auteur]
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Charlon, S. [Auteur]
Ecole nationale supérieure Mines-Télécom Lille Douai [IMT Lille Douai]
Verin, Jérémy [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Freitag, J. [Auteur]
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Siepmann, Florence [Auteur]

Advanced Drug Delivery Systems (ADDS) - U1008
Soulestin, J. [Auteur]
Ecole nationale supérieure Mines-Télécom Lille Douai [IMT Lille Douai]
Siepmann, Juergen [Auteur]

Advanced Drug Delivery Systems (ADDS) - U1008

Titre de la revue :

Journal of Controlled Release

Nom court de la revue :

J Control Release

Numéro :

353

Pagination :

864-874

Éditeur :

Elsevier

Date de publication :

2022-12-19

ISSN :

1873-4995

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

3D Printing offers a considerable potential for personalized medicines. This is especially true for customized biodegradable implants, matching the specific needs of each patient. Poly(lactic-co-glycolic acid) (PLGA) is ...
Lire la suite >3D Printing offers a considerable potential for personalized medicines. This is especially true for customized biodegradable implants, matching the specific needs of each patient. Poly(lactic-co-glycolic acid) (PLGA) is frequently used as matrix former in biodegradable implants. However, yet relatively little is known on the technologies, which can be used for the 3D printing of PLGA implants. The aim of this study was to compare: (i) Arburg Plastic Freeforming Droplet Deposition Modeling (APF DDM), and (ii) Fused Deposition Modeling (FDM) to print mesh-shaped, ibuprofen-loaded PLGA implants. During APF DDM, individual drug-polymer droplets are deposited, fusing together to form filaments, which build up the implants. During FDM, continuous drug-polymer filaments are deposited to form the meshes. The implants were thoroughly characterized before and after exposure to phosphate buffer pH 7.4 using optical and scanning electron microscopy, GPC, DSC, drug release measurements and monitoring dynamic changes in the systems' dry & wet mass and pH of the bulk fluid. Interestingly, the mesh structures were significantly different, although the device design (composition & theoretical geometry) were the same. This could be explained by the fact that the deposition of individual droplets during APF DDM led to curved and rather thick filaments, resulting in a much lower mesh porosity. In contrast, FDM printing generated straight and thinner filaments: The open spaces between them were much larger and allowed convective mass transport during drug release. Consequently, most of the drug was already released after 4 d, when substantial PLGA set on. In the case of APF DDM printed implants, most of the drug was still entrapped at that time point and substantial polymer swelling transformed the meshes into more or less continuous PLGA gels. Hence, the diffusion pathways became much longer and ibuprofen release was controlled over 2 weeks.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
Inserm
CHU Lille

Collections :

Advanced Drug Delivery Systems (ADDS) - U1008

Date de dépôt :

2023-02-22T01:29:37Z
2023-03-03T10:49:37Z

Fichiers

Bassand_JCR_353_864-874.pdf
Non spécifié
Accès libre
Accéder au document

Historique des modifications

Numéro de version	Lien	Date de modification
3	20.500.12210/79185	2024-04-02T13:07:54Z
2	20.500.12210/79185.2*	2023-03-03T10:08:15Z
1	20.500.12210/79185.1	2023-02-22T01:29:37Z

*Version sélectionnée